[Prognosis factors in imatinib mesilate therapy in patients with a chronic phase of Ph-positive chronic myeloid leukemia: data from a multicenter non-randomized trial in Russia].

Saved in:
Bibliographic Details
Title: [Prognosis factors in imatinib mesilate therapy in patients with a chronic phase of Ph-positive chronic myeloid leukemia: data from a multicenter non-randomized trial in Russia].
Authors: Zaritskiĭ AIu, Lomaia EG, Vinogradova OIu, Druzhkova GA, Kolosheĭnova TI, Loria SS, Pospelova TI, Krylova IV, Kruglov SS, Kuznetsov SV, Chelysheva EIu, Abakumov EM, Sokolova MA, Nemchenko IS, Zakharova ES, Goriacheva SR, Kolosova LIu, Vakhrusheva MV, Liamkina AS, Chernova OA, Machiulaĭtene ER, Ivanova VL, Udal'eva VIu, Shneĭder TV, Ogorodnikova IuS, Zhuravlev VS, Zakharova AV, Martynkevich IS, Domracheva EV, Afanas'ev BV, Abdulkadyrov KM, Kovaleva LG, Khoroshko ND, Turkina AG
Source: Terapevticheskii arkhiv [Ter Arkh] 2007; Vol. 79 (8), pp. 17-22.
Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study
Journal Info: Publisher: ZAO 'Konsilium Medikum Country of Publication: Russia (Federation) NLM ID: 2984818R Publication Model: Print Cited Medium: Print ISSN: 0040-3660 (Print) Linking ISSN: 00403660 NLM ISO Abbreviation: Ter Arkh Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0040-3660